Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Profit After Tax (2021 - 2026)

HeartSciences' Profit After Tax history spans 6 years, with the latest figure at -$2.0 million for Q1 2026.

  • For Q1 2026, Profit After Tax rose 21.73% year-over-year to -$2.0 million; the TTM value through Jan 2026 reached -$8.5 million, changed 0.37%, while the annual FY2025 figure was -$8.8 million, 32.7% down from the prior year.
  • Profit After Tax reached -$2.0 million in Q1 2026 per HSCS's latest filing, up from -$2.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$1.2 million in Q1 2022 to a low of -$2.5 million in Q1 2025.
  • Average Profit After Tax over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2024.
  • Peak YoY movement for Profit After Tax: tumbled 213.5% in 2022, then rose 21.73% in 2026.
  • A 5-year view of Profit After Tax shows it stood at -$1.8 million in 2022, then increased by 3.22% to -$1.7 million in 2023, then dropped by 19.13% to -$2.1 million in 2024, then dropped by 12.86% to -$2.4 million in 2025, then increased by 15.55% to -$2.0 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Profit After Tax are -$2.0 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.1 million (Q3 2025).